Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C401-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate |
1997-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7995e5ab03618992c6a209e5213bcfe0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_520b9cd7b131ee4f1cb8e81827df580c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acd55f0399bf4c68ee3221b17e90bdf5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_647ca6c8d8f0308aa11dbc8971411480 |
publicationDate |
1998-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-H10265453-A |
titleOfInvention |
1α, 24-dihydroxy-25-nitrovitamin D3 derivative and method for producing the same |
abstract |
(57) [Problem] To provide a drug useful as a therapeutic drug for a disease in which calcium metabolism or cell differentiation function is abnormal, and a method for producing the same. SOLUTION: The following formula (I) Wherein A and B are hydrogen atoms or together represent a carbon-carbon bond, and an asterisk indicates that the configuration for that carbon is either the R configuration or the S configuration. Represent. L [alpha], 24- dihydroxy-25-nitro vitamin D 3 derivatives, and manufacturing method thereof represented by. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5248115-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007064011-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8173824-B2 |
priorityDate |
1997-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |